Add like
Add dislike
Add to saved papers

Multi-state nonadiabatic deactivation mechanism of coumarin revealed by ab initio on-the-fly trajectory surface hopping dynamic simulation.

An on-the-fly trajectory surface hopping dynamic simulation has been performed for revealing the multi-state nonadiabatic deactivation mechanism of coumarin. The mechanism involves three adiabatic excited states, S3 (ππ*Lb ), S2 (nπ*, ππ*La ) and S1 (ππ*La , nπ*), and the ground state S0 at the four state-averaged complete active space self-consistent field, SA4-CASSCF(12,10)/6-31G* level of theory. Upon photoexcitation to the third excited state S3 (ππ*Lb ) in the Franck-Condon region, 80% sampling trajectories decay to the dark S2 (nπ*) state within an average of 5 fs via the conical intersection S3 (ππ*Lb )/S2 (nπ*), while 20% decay to the S2 (ππ*La ) state within an average of 11 fs via the conical intersection S3 (ππ*Lb )/S2 (ππ*La ). Then, sampling trajectories via S2 (nπ*)/S1 (ππ*La ) continue with ultrafast decay processes to give a final distribution of quantum yields as follows: 42% stay on the dark S1 (nπ*) state, 43.3% go back to the ground S0 state, 12% undergo a ring-opening reaction to the Z-form S0 (Z) state, and 2.7% go to the E-form S0 (E) state. The lifetimes of the excited states are estimated as follows: the S3 state is about 12 fs on average, the S2 state is about 80 fs, and the S1 state has a fast component of about 160 fs and a slow component of 15 ps. The simulated ultrafast radiationless deactivation pathways of photoexcited coumarin immediately interpret the experimentally observed weak fluorescence emission.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app